Opinion

Video

Practice Patterns and Real Use of Epcoritamab and Glofitamab

A panel of experts discuss the role of odronextamab.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    • Briefly describe the role of odronextamab, after the FDA Complete Response Letter sent in March requiring active enrollment in the confirmatory portion of the Phase 3 OLYMPIA trial.

    Newsletter

    Stay up to date on the most recent and practice-changing oncology data

    Related Content